Overview
McDermott was noted as legal counsel to Marseille biopharma company Innate Pharma, which develops therapeutic antibodies against cancer and inflammatory diseases, for a research-focused agreement with AstraZeneca and the MedImmune R&D unit worth up to $ 1.275 billion.